Navigation Links
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Date:6/2/2009

Potential Seven Years Market Exclusivity in PHN Pending Product Approval

SAN MATEO, Calif., June 2 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that the Office of Orphan Product Development (OOPD) of the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Qutenza(TM) (formerly NGX-4010), a high concentration capsaicin dermal patch for the management of neuropathic pain in patients with postherpetic neuralgia (PHN).

The FDA is currently reviewing the Company's new drug application (NDA) for Qutenza in PHN and has assigned a Prescription Drug User Fee Act (PDUFA) date of August 16, 2009. Qutenza, if approved by the FDA, would benefit from seven years of market exclusivity in PHN as a result of this orphan designation.

The U.S. Orphan Drug Act encourages the development of products that demonstrate promise for the diagnosis, prevention and/or treatment of rare diseases and conditions affecting 200,000 patients or less. Orphan drug designation is an important economic incentive for the development of new products, providing seven years of exclusive marketing rights during which the FDA will not approve the same drug from another sponsor for the same orphan indication during the exclusivity period. In addition, orphan designation allows for reduction in certain regulatory fees, and additional regulatory support for R&D initiatives.

Anthony DiTonno, President and CEO, commented, "The FDA's orphan designation underscores the unmet need of patients suffering from PHN and may serve to strengthen Qutenza's competitive position through seven years of market exclusivity upon approval."

PHN is a chronic painful condition that develop
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
2. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
3. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
6. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
7. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
8. AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
9. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
10. Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
11. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the ... acquired Polaris Medical Imaging, a leader in sales, service ... strategic acquisition allows BC Technical to continue to expand ... within MR and CT modalities. "We ... said Mark Alvarez , president and CEO of ...
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4BC Technical Acquires Polaris Medical Imaging 2US CNS Disorders Drug Pipeline Insight 2014 2
... 2010 General-use X-ray security systems are one ... to widespread use to check people entering secured ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... the low risk to health associated with these ...
... N.Y., Nov. 4, 2010 At a special meeting today, ... approve the merger of West Acquisition Corp., an indirect wholly ... ), with and into Penwest and voted to approve the ... Penwest, West and Endo.   The merger became ...
Cached Medicine Technology:
(Date:8/31/2014)... August 31, 2014 The severity of ... provider specializing in menopause is expert in helping ... and relief from uncomfortable symptoms with the latest treatment ... therapies offer a variety of alternative treatments and products ... these treatment options may fall outside of what can ...
(Date:8/31/2014)... Sunday 31 August 2014: Drinking tea reduces non-cardiovascular ... people presented at ESC Congress today by Professor Nicolas ... have to choose between tea or coffee it,s probably ... components of our way of life. Their effects on ... with sometimes divergent results. We investigated the effects of ...
(Date:8/30/2014)... Spain Sunday 31 August 2014: Local anaesthetic is ... (TAVI) as general anaesthetic, according to results of the ... Dr Romain Chopard from France. , Dr Chopard said: ... treatment alternative for patients with severe symptomatic aortic stenosis ... conventional surgical aortic valve replacement. The number of TAVI ...
(Date:8/30/2014)... Orlando, Florida (PRWEB) August 31, 2014 ... gait walking and how a mobility device can help in ... now available for free download from the website that contains ... medical doctor for this site. , The articles deal with ... mobility device like a walking cane can help in making ...
(Date:8/30/2014)... In a world where a typical response ... Group, LLC launches a game app to teach another way. ... Ultimate Karma app is a colorful way to encourage moral ... the game pulls double-duty by teaching players new ways to ... to reward gamers for consistently taking the high road, the ...
Breaking Medicine News(10 mins):Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2
... , SATURDAY, June 20 (HealthDay News) -- Mowing the ... people forget that their lawn mower can cause serious ... States, about 200,000 people (including 16,000 children) are injured ... Product Safety Commission. Those injuries include severed fingers, toes ...
... 600 Kidney-Friendly Recipes to Meet Kidney Care Needs for Dads ... Inc. (NYSE: DVA ), a leading provider of ... (CKD), offers fathers and their families the opportunity to enjoy ... 600 kidney-friendly recipes available on DaVita.com . ...
... U.S. Senator Amy Klobuchar to visit Healthy Athletes Village and ... Today is the last day to catch Summer Games action ... Klobuchar will visit Healthy Athletes Village today from 9:30-10 a.m. ... from 10-10:30 a.m. at Bierman Field. , , Healthy ...
... imaging equipment is in use in outpatient settings does ... Payment Advisory Commission (MedPAC) recommend Medicare utilize to calculate ... the Radiology Business Management Association (RBMA), a national association ... data, which consist of 261 imaging machines in 46 ...
... , SEATTLE, June 19 /PRNewswire-FirstCall/ -- ... CTIC) today announced the final results of its separate concurrent ... the "Exchange Offers") for any and all of the approximately ... convertible notes (the "Notes"). The Exchange Offers expired at ...
... As President Obama prepares to sign a bill giving ... tobacco industry, a new study from Harvard School of ... continually changed the ingredients and the design of their ... acceptable product variance guidelines. The result, say the researchers, ...
Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 3Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 2Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 2Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 4Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2
A One Piece Support Garment - any length or size...
Body Suit w/Bra torso...
Male Compression Vest Binder...
Ideal for breast compression with adjustable hook and eye closure....
Medicine Products: